Paul A. Romness
Founder, Chairman, President & CEOMr. Paul A. Romness, MPH, is Founder, President, Chief Executive Officer and Director of OS Therapies Incorporated since April 2018 and as its Chairman from October 2024. Prior to founding OS Therapies Incorporated Mr. Romness served as a Principal for PR Strategies from 2014 to March 2018. Prior to PR Strategies, Mr. Romness served as the Vice President of Government Affairs and Public Policy at Boehringer Ingelheim from 2008 to 2014 and the Director of State Government Affairs at Amgen Inc. from March 2005 to March 2008. Earlier in his career, Mr. Romness served in several roles at Johnson & Johnson from March 1990 to March 2003. Mr. Romness holds a Masters of Public Health from the Milken Institute School of Public Health in Health Policy of George Washington University and a B.S. degree in Finance from American University. His experience in the biopharmaceutical industry, day-to-day operational leadership of company and in-depth knowledge of product candidates and platform technologies make him well qualified as a member of Board.
Positions
- Company NameOS Therapies IncorporatedStock CodeOSTXPositionFounder, Chairman, President & CEOColleagues
- RGRobert G. PetitChief Medical Officer & Chief Scientific Officer
- FKFrancis KnuettelChief Financial Officer
- JDJack DollChief of Staff
- GEGerald E. CommissiongChief Business Officer
- JCJohn CiccioIndependent Director
- TFTheodore F. SearchIndependent Director
- JWJutta WannerMember of Antibody Drug Conjugate (ADC) Advisory Board
- OEOlivia EggeMember of Patient Advocacy Advisory Board
